BlackRock
ABBV icon

BlackRock’s AbbVie ABBV Stock Holding History

BlackRock’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.2M Buy
+51,500
New +$11.4M ﹤0.01% 3427
2016
Q4 		– Sell
-1,500
Closed -$95K – 3723
2016
Q3 		$95K Buy
+1,500
New +$97.1K ﹤0.01% 2621

Other funds holding ABBV

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock's ABBV Position: Q1 2026 in Review

BlackRock reduced its AbbVie (ABBV) stake by 0.32% in Q1 2026, selling an estimated $106M and leaving 150,698,125 shares worth $32.8B. The position accounts for 0.57% of the portfolio, ranked #22.

BlackRock first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $34.5B in Q4 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • BlackRock held 150,698,125 shares of AbbVie worth $32.8B as of Q1 2026.
  • BlackRock sold 476,418 AbbVie shares in Q1 2026, an estimated $106M.
  • AbbVie made up 0.57% of BlackRock's portfolio in Q1 2026, its #22 holding.
  • BlackRock first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • BlackRock's AbbVie position peaked at $34.5B in Q4 2025.
  • 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.